Patient P-03177
Therapy response
Unstable
Tolerance
Deteriorating
GI state
Stable
Inflammatory state
Deteriorating
Nutritional resilience
Stable
Discontinuation risk
31%
Trajectory
Baseline → today → 30-day prediction · hover a day for signals and eventssolid = observed · dashed = predicted
- Day 0 ONX-7 started — Baseline state S01
- Day 21 Trajectory diverged from prediction — Observed response fell below the model's expected path.
What changed?
Trajectory began diverging from predicted response on Day 21.
Primary contributors, last 14 days
- Toxicity+10
- Inflammatory activity+4
- Treatment adherence-4
- GI instability+3
- Nutritional resilience+3
What helped?
No interventions yet.
LIFE OS recommendation
Dosing / Timing Recommendation DT-01
55%
probability of meaningful tolerance improvement
- 284 similar trajectories
- 77% showed improvement
- median effect visible after 5 days
Daily trackers
Molecule settingsThe trackers this program marks as important, last 14 days vs the 14 before.
Energy level
Daily log4.5/10
worsening · -0.4 vs previous 14 d
Stress level
Daily log3.7/10
worsening · +0.5 vs previous 14 d
Pessimism score
Daily log4.7/10
worsening · +0.4 vs previous 14 d
Sleep quality
Wearable45/100
worsening · -3.1 vs previous 14 d
Libido
Daily log4.9/10
worsening · -0.2 vs previous 14 d
HRV
Wearable60.9 ms
stable · -2.6 vs previous 14 d
Toxicity
Blood17.6/100
worsening · +1.3 vs previous 14 d
This trajectory is decaying — what would help, what would not
Steering view →Heading towards failing · 43 from the failing basin, 56 from restoration.
Would help
Would not help
- AD-05 Adherence Supportonly 31% improved among 13 similar
- Keep histamine lowGI +5 next day on high-intake days · n 20
- Keep lactose lowGI +2.9 next day on high-intake days · n 29
State influencers · digestive
Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.
- Histamine load+5detractor · 95%
- Protein-4.7supporter · 95%
- Lactose+2.9detractor · 76%
- Alcohol+1.3no signal · 23%
- Caffeine-1.1no signal · 27%
- Dietary fat load+0.1no signal · 15%
Biological layers
Which pathways look influenced, and by which layer of this person's biology.
Pathways under pressure
- Mucosal barrier integrity ↓60
- DNAFUT2 non-secretor lowers mucosal fucosylation
- MicrobiomeAkkermansia low → thinner mucus layer
- Autonomic recovery ↑25
- WearableResting HR 81 bpm
- Inflammatory signalling ↑20
- MicrobiomeBacteroides fragilis expansion
DNA
Fictional pharmacogenomic panel
- FUT2 rs601338 AA (non-secretor)Reduced mucosal fucosylation
- CYP2D6 Normal metabolizerExpected exposure
Microbiome
Shannon diversity 3 · butyrate capacity 52/100
- Akkermansia muciniphilaLow
- Faecalibacterium prausnitziiNormal
- Bacteroides fragilisHigh
- Bifidobacterium longumLow
- EnterobacteriaceaeNormal
Wearable, last 14 days
daily evolution fed into the runtime
- HRV
- 64 ms
- Sleep
- 7.1 h
- Steps
- 4,540
- Resting HR
- 77 bpm
Daily log: GI score 40, nutritional resilience 55, adherence 85.
What this patient sees in NostraAI
The content that steers the trajectory: what to eat, what to do, what to take.
What to eat
- Prepare a plain, low-fat pasta or rice meal and note how it feels afterwards
- Choose a freshly cooked, lean protein; avoid frying, rich sauces and leftovers for now
- Keep fibre steady; no new sources this week
- Avoid known triggers for now: fried or oily food, dairy, alcohol
What to do
- Track each bowel movement today: time, stool form, urgency, overnight waking
- A 15-minute walk after lunch
- Keep the sleep window steady
- Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
- Take the scheduled dose as agreed with your care team
- Electrolyte solution, one sachet after any loose stool
- Fictional demo item: continue vitamin D as before
284 biologically similar trajectories
Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.